◼ Archived
Business
🔮 fades ✗
Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody
Roche has secured a global licensing pact with Simcere Zaiming for an experimental B-cell-targeting antibody.
1 trends tracked about this subject — the full history, oldest to newest below.
Roche has secured a global licensing pact with Simcere Zaiming for an experimental B-cell-targeting antibody.